Two REMS, Two Names, One Drug: Is It Safe? FDA Questions Jazz's Proposal For Fibromyalgia Indication
Advisory panel on sodium oxybate will weigh whether separate REMS for Xyrem and proposed Rekinla can prevent medication errors and abuse.
Advisory panel on sodium oxybate will weigh whether separate REMS for Xyrem and proposed Rekinla can prevent medication errors and abuse.